NASDAQ · Medical Care Facilities · USD

NewGenIvf Group Limited (NIVF) Stock Analysis

NewGenIvf Group Limited (NIVF) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

NIVF

$0.19

−$0.06 (−24.61%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NIVF with… →

NIVF Key Statistics

As of Oct 21, 2026

Trading

Open: $0.20
Previous Close: $0.25
Day's Range: 0.18–0.20
52-Week Range: 0.17–2,829.60
Volume: 14.58M
Beta: 0.06

Valuation

Market Cap: $1.29M
Forward P/E: 0.00
P/S ratio: 0.28

Financials (FY)

Revenue (FY): $4.73M−13.01%
Net Income (FY): $9.88M
Profit margin: 24.16%
Shares Outstanding: 6.82M
1-Year Return: −99.99%

Dividend and dates

Avg Volume: 9.91M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, NIVF closed at $0.19, −99.99% over 1 year.

NewGenIvf Group Limited (NIVF) has a market capitalization of $1.29M.

In fiscal 2025, NIVF reported revenue of $4.73M.

NIVF Stock Return by Calendar Year

NewGenIvf Group Limited (NIVF) return since Mar 2022: what $10,000 became

1 year: $10,000 $0.72; −99.99%
3 years: $10,000 $0.0001; −99.999999%
Since Mar 2022: $10,000 $0.0001; −99.999999%

If you had invested $10,000 in NewGenIvf Group Limited (NIVF) at the close on March 18, 2022, the earliest close on record here, it would have been worth $0.0001 at the close on October 21, 2026: −99.999999% in total, −98.23% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

+3.76%+6.86%−96.28%−99.97%−99.94%

2022*2023202420252026*

Year	Return
2026 (partial year)	−99.94%
2025	−99.97%
2024	−96.28%
2023	+6.86%
2022 (partial year)	+3.76%

As of October 21, 2026.

NIVF Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$4.73M	$9.88M	209.0%
2024	$5.43M	−$524.64K	−9.7%
2023	$5.14M	$130.19K	2.5%
2022	$5.94M	$458.67K	7.7%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$4.73M	$955.85K	−$10.73M	$9.88M	209.0%
2024	$5.43M	$1.83M	−$1.16M	−$524.64K	−9.7%
2023	$5.14M	$1.68M	$42.24K	$130.19K	2.5%
2022	$5.94M	$1.54M	$398.71K	$458.67K	7.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NIVF Valuation vs Medical Care Facilities Median

Median of 54 stocks

Metric	NIVF	Medical Care Facilities median	vs median
P/S ratio	0.28	0.87	0.3x the median
Profit margin	24.16%	3.19%	21.0 pts above

Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

NewGenIvf Group Limited (NIVF) is capitalised at $1.29M on the latest close. It is classified in the Medical Care Facilities industry, within the Healthcare sector. Headcount on file is 87.

Over the past 52 weeks the price has ranged from $0.17 to $2,829.60. NIVF last closed at $0.19 on October 21, 2026. That is −$0.06 (−24.61%) against the previous close. The latest close sits 9.53% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $4.73M. That is −13.01% against the prior fiscal year, when revenue was $5.43M. The same year closed with net income of $9.88M. Profit margin runs at 24.16%. That is 21 percentage points above the Medical Care Facilities median of 3.19%.

Across the 4 fiscal years on file, revenue moves from $5.94M in 2022 to $4.73M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

On forward earnings the ratio is 0. The price-to-sales ratio is 0.28. On price-to-sales that is 0.3 times the Medical Care Facilities median of 0.87. 54 Medical Care Facilities companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −99.99%. Across 3 years the annualized return works out at −99.80%. Beta against the wider market is reported at 0.06. Daily returns over the trailing 4 years annualize to a volatility of 198.28%.

Growth & Income

No dividend is on file for NIVF.

The strongest complete calendar year on file is 2023 at +6.86%; the weakest is 2025 at −99.97%. Of the 3 complete calendar years on file, 1 finished higher. So far in 2026 the total return is −99.94%.

Peer Comparison

NewGenIvf Group Limited (NIVF) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
NewGenIvf Group Limited	NIVF	$1.29M	—
HCA Healthcare, Inc.	HCA	$99.46B	15.4
Tenet Healthcare Corporation	THC	$21.67B	10.6
Encompass Health Corporation	EHC	$11.88B	20.2

The Medical Care Facilities industry average P/E ratio is 20.7x. NewGenIvf Group Limited has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$99.46B

THC

Tenet Healthcare Corporation

$21.67B

EHC

Encompass Health Corporation

$11.88B

FMS

Fresenius Medical Care AG

$11.47B

DVA

DaVita Inc.

$11.28B

UHS

Universal Health Services, Inc.

$10.78B

View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About NewGenIvf Group Limited

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Visit website →